scorecardresearchSun Pharma Advanced Research Com Share Price Live NSE, BSE, Today - Sun

Sun Pharma Advanced Research Com

BSE: 532872 | NSE: SPARC | ISIN: INE232I01014 | SECTOR: Business Services

211.55 -4.20 (-1.95%)

22 May 2024, 10:23 (IST)
  • Open

    218.90
  • High

    218.90
  • Low

    208.50
  • Prev Close

    215.75
  • P/E

    -
  • Median P/E

    -
  • P/B

    -
  • Median P/B

    -
  • Market Cap

    68.65B
  • Volume

    34.11K
  • Vol. (20 day Avg.)

    0
  • PEG

    -
  • Div.Yield

    -
  • Bid

    211.55
  • Ask

    -

Promoter Pledge Holding - 1.82%

Promoter NameNo of SharesPercentage
Sudhir Valia18,00,0000.55%
Raksha S.Valia41,20,0001.27%

Company Description

  • Business Services
  • BSE

    532872
  • NSE

    SPARC
  • ISIN

    INE232I01014

Sun Pharma Advanced Research Company Limited is an India-based clinical-stage bio-pharmaceutical company. The Company is in the business of research and development (R&D) of pharmaceutical products to unmet medical needs in the areas of oncology, neurodegeneration and immunology. The Company develops New Chemical Entities (NCE), New Biological Entities and reformulated products. Its NCE includes SCC-138, SCO-088, SCO-120 and SCD-044. Its Novel Drug Delivery Systems (NDDS) include Wrap Matrix Technology, Lipexelle technology and TearAct Technology. Wrap Matrix technology is useful to develop controlled release tablets. It has developed Elepsia XR using Wrap MatrixTM technology. Lipexelle technology for ophthalmic formulations. It has also developed Xelpros, a BAK free latanoprost eye drop developed using Lipexelle technology. Xelpros is commercialized by its partner in the United States. It has also developed PDP-716 eye drops for treatment of Glaucoma based on its TearAct technology.

Company Officers

  • Anilkumar Raghavan

    Chief Executive Officer
  • Chetan Rajpara

    Chief Financial Officer
  • Kajal Damania

    Compliance Officer, Company Secretary